Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

BIOTECH STOCKS STAR ON WALL ST.

Jan. 2, 1992

INTERNEURON DENIES DRUG TOXICITY

Dec. 31, 1991

NOVA FILES IND FOR ANTI-INFLAMMATORY

Dec. 31, 1991

THE YEAR AHEAD: NIH DIRECTOR MEANS BUSINESS

Dec. 31, 1991

CROP, DU PONT SIGN DEAL FOR INSECTICIDES

Dec. 30, 1991

CDC FINALIZES VACCINATION RECOMMENDATION

Dec. 30, 1991

SYNERGEN, XOMA STOCK UP

Dec. 30, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 30, 1991

THE YEAR AHEAD: BIOTECH LEGISLATION

Dec. 30, 1991

CHIRON, CIBA REVISE VACCINE AGREEMENTS

Dec. 27, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...